Neurobiology Research Center Awards 7 Peer-Reviewed Pilot Grants

The University of Cincinnati (UC) Neurobiology Research Center and the UC Gardner Neuroscience Institute recently awarded seven researchers with peer-reviewed pilot grants totaling $175,000. Awardees each receive a $25,000 grant toward their pilot research. 

"Our goal with these pilot grants is to advance neuroscience research efforts across the university,” says James Herman, PhD, Donald C. Harrison Professor of Psychiatry and Behavioral Neuroscience and director of the UC Neurobiology Research Center (NRC). "Pilot grants not only foster collaboration across different disciplines to further thinking and research in the neurosciences, but also can lead to national funding of the research project.” 

Herman says that NRC grants funded in recent years have paired pharmacy researchers with the UC Brain Tumor Center, psychiatry with internal medicine, and neurology and environmental health, to name a few, and that these collaborations "can go on to be competitive for NIH funding, which is the ultimate goal.” 

In addition to the NRC, funding for these pilot awards comes from the UC Gardner Neuroscience Institute, George J. and Elizabeth Wile Neuroscience Research Endowment, the Department of Psychiatry and Behavioral Neuroscience, Patient-Centered Outcomes Research Institute (PCORI) and Meshawa Farms. 

"With each year, we continue to have a good translational emphasis,” adds Herman. "Of this year’s awards, three are clinical, three are basic science and one is truly translational (testing a possible new therapy for glioblastoma using preclinical approaches).”

2017 recipients are:
  • Oluwole Awosika, MD, assistant professor, Department of Neurology and Rehabilitation Medicine Enhancing Locomotion in Stroke: A Non-Invasive Neuromodulatory Approach
  • Mary Beth Genter, PhD, professor, Department of Environmental Health
     Intranasal Nilotinib in a Mouse Model of Parkinson’s Disease
  • Adam Jasne, MD, fellow, Department of Neurology and Rehabilitation Medicine
    Epidemiology of Rural/Urban Disparities in Stroke
  • Laura Ngwenya, MD, PhD, assistant professor, Department of Neurosurgery
    Substrates Underlying TBI-Induced Cognitive Deficit
  • Smruti Patel, MD, resident, Department of Neurosurgery
    Developing Novel Preclinical Models of Brain Tumors With in Utero Electroporation
  • Atsuo Sasaki, PhD, associate professor, Department of Internal Medicine, Division of Hematology Oncology
    Development of a New Adjuvant Modality Targeting GTP Metabolism for GBM Therapy
  • Eric Wohleb, PhD, assistant professor, Department of Psychiatry and Behavioral Neuroscience
    Neuronal Modulation of Microglia Function: Implications for Synaptic Plasticity

Tags

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.